124 related articles for article (PubMed ID: 10595933)
1. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms.
Horie R; Gattei V; Ito K; Imajo-Ohmi S; Tange T; Miyauchi J; Pinto A; Degan M; De Iuliis A; Tassan Mazzocco F; Rossi FM; Higashihara M; Watanabe T
Am J Pathol; 1999 Dec; 155(6):2029-41. PubMed ID: 10595933
[TBL] [Abstract][Full Text] [Related]
2. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages.
Horie R; Ito K; Tatewaki M; Nagai M; Aizawa S; Higashihara M; Ishida T; Inoue J; Takizawa H; Watanabe T
Blood; 1996 Oct; 88(7):2422-32. PubMed ID: 8839832
[TBL] [Abstract][Full Text] [Related]
3. Study of gene expression of CD30 variant (CD30v) and CD30 ligand (CD30L) in acute leukemia.
Essa EA; El Halim SM; Abo-Elenin A; El Bendary A; Abdou SH; Farag W
Egypt J Immunol; 2007; 14(1):11-20. PubMed ID: 18689277
[TBL] [Abstract][Full Text] [Related]
4. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
5. TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation.
Thakar NY; Ovchinnikov DA; Hastie ML; Kobe B; Gorman JJ; Wolvetang EJ
Mol Biol Cell; 2015 Mar; 26(5):993-1006. PubMed ID: 25568342
[TBL] [Abstract][Full Text] [Related]
6. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
9. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.
Zapata JM; Krajewska M; Krajewski S; Kitada S; Welsh K; Monks A; McCloskey N; Gordon J; Kipps TJ; Gascoyne RD; Shabaik A; Reed JC
J Immunol; 2000 Nov; 165(9):5084-96. PubMed ID: 11046039
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the RET gene in human acute myeloid leukemia.
Gattei V; Degan M; Aldinucci D; De Iuliis A; Rossi FM; Mazzocco FT; Rupolo M; Zagonel V; Pinto A
Ann Hematol; 1998 Nov; 77(5):207-10. PubMed ID: 9858145
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T
Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717
[TBL] [Abstract][Full Text] [Related]
12. Functional platelet-activating factor receptors in immature forms of leukemic blasts.
Reynaud S; Malissein E; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2007 Mar; 31(3):399-402. PubMed ID: 16837045
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the monocyte-specific esterase (MSE) gene.
Uphoff CC; Hu ZB; Gignac SM; Ma W; Rainey FA; Kreutz M; Ludwig WD; Drexler HG
Leukemia; 1994 Sep; 8(9):1510-26. PubMed ID: 8090031
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
18. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
20. The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation.
Gattei V; Degan M; Rossi FM; De Iuliis A; Mazzocco FT; Cesa E; Aldinucci D; Zagonel V; Pinto A
Br J Haematol; 1999 Apr; 105(1):225-40. PubMed ID: 10233387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]